Evidence map›Paper›PMID 19380585›Full record

ArticleThe Journal of biological chemistry2009

Substituted cysteine accessibility method analysis of human concentrative nucleoside transporter hCNT3 reveals a novel discontinuous region of functional importance within the CNT family motif (G/A)XKX3NEFVA(Y/M/F).

Melissa D Slugoski, Amy M L Ng, Sylvia Y M Yao, Colin C Lin, Ras Mulinta, Carol E Cass, Stephen A Baldwin, James D Young

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Melissa D SlugoskiFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Amy M L NgFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Sylvia Y M YaoFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Colin C LinFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Ras MulintaFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Carol E CassOncology, Membrane Protein Research Group, University of Alberta, Edmonton, Alberta T6G 2H7, Canada; Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, Canada.
Stephen A BaldwinAstbury Centre for Structural Molecular Biology, Institute of Membrane and Systems Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
James D YoungFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada. Electronic address: james.young@ualberta.ca.
Institute of Structural and Molecular Biology · GBUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human SLC28 family of integral membrane CNT (concentrative nucleoside transporter) proteins has three members, hCNT1, hCNT2, and hCNT3. Na(+)-coupled hCNT1 and hCNT2 transport pyrimidine and purine nucleosides, respectively, whereas hCNT3 mediates transport of both pyrimidine and purine nucleosides utilizing Na(+) and/or H(+) electrochemical gradients. These and other eukaryote CNTs are currently defined by a putative 13-transmembrane helix (TM) topology model with an intracellular N terminus and a glycosylated extracellular C terminus. Recent mutagenesis studies, however, have provided evidence supporting an alternative 15-TM membrane architecture. In the absence of CNT crystal structures, valuable information can be gained about residue localization and function using substituted cysteine accessibility method analysis with thiol-reactive reagents, such as p-chloromercuribenzene sulfonate. Using heterologous expression in Xenopus oocytes and the cysteineless hCNT3 protein hCNT3C-, substituted cysteine accessibility method analysis with p-chloromercuribenzene sulfonate was performed on the TM 11-13 region, including bridging extramembranous loops. The results identified residues of functional importance and, consistent with a new revised 15-TM CNT membrane architecture, suggest a novel membrane-associated topology for a region of the protein (TM 11A) that includes the highly conserved CNT family motif (G/A)XKX(3)NEFVA(Y/M/F).

Indexed as

4-ChloromercuribenzenesulfonateAmino Acid MotifsAmino Acid SequenceAmino Acid SubstitutionAnimalsBinding SitesCysteineFemaleHumansIn Vitro TechniquesMembrane Transport ProteinsModels, MolecularMutagenesis, Site-DirectedNucleosidesOocytesProtein Structure, Secondary4-Chloromercuribenzenesulfonatecif nucleoside transporterCysteineMembrane Transport ProteinsNucleosidesRecombinant ProteinsUridine

Identifiers

PMID19380585
PMCPMC2719364
OpenAlexW1973455687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.